HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc > BC Drug Plan

<< Previous

Bullboard Posts

Comment by screamer99on Jul 29, 2024 8:13pm

119 Views

Post# 36153569

RE:BC Drug Plan

Now we know what that 400k+ (hitting the ask) trade was about last Wednesday.

Took a little longer than expected for the AB Drug Plan, but now we're here.

Will take several quarters for the market to get excited about this but whenever the amortization drops off (haven't bothered to look) and we can show positive EPS, the ride will start.

Until then, reasonable cash flows and maybe some growth will get more intersted in this one.

<< Previous

Bullboard Posts

Cybin launches new program phase to treat Major Depressive Disorder